clover health investments - CLOV
CLOV
Close Chg Chg %
3.37 0.10 2.97%
Open Market
3.47
+0.10 (2.97%)
Volume: 584.99K
Last Updated:
Nov 25, 2024, 9:42 AM EDT
Company Overview: clover health investments - CLOV
CLOV Key Data
| Open $3.43 | Day Range 3.43 - 3.50 |
| 52 Week Range 0.61 - 4.71 | Market Cap $1.69B |
| Shares Outstanding 501.11M | Public Float 376.94M |
| Beta 2.04 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.19 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 7.26M |
CLOV Performance
| 1 Week | 0.00% | ||
| 1 Month | -14.03% | ||
| 3 Months | 0.90% | ||
| 1 Year | 224.04% | ||
| 5 Years | N/A |
CLOV Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
3
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 3.067 | |
| Number of Ratings | 3 | Current Quarters Estimate | -0.068 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | -0.118 | |
| Last Quarter’s Earnings | -0.02 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.442 | Next Fiscal Year Estimate | -0.138 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 3 | 3 | 3 | 3 |
| Mean Estimate | -0.07 | -0.04 | -0.12 | -0.14 |
| High Estimates | -0.06 | -0.03 | -0.11 | -0.07 |
| Low Estimate | -0.07 | -0.06 | -0.12 | -0.18 |
| Coefficient of Variance | -5.23 | -33.43 | -2.77 | -43.32 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 1 | 1 | 1 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 2 | 2 | 2 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Clover Health Investments - CLOV
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Clover Health Investments - CLOV
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jul 23, 2024 | Brady Patrick Priest CEO of Home Care | 1,866,199 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.69 per share | 3,153,876.31 |
| Jul 4, 2024 | Andrew Toy Chief Executive Officer; Director | 10,196,029 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.2 per share | 12,235,234.80 |
| Jul 3, 2024 | Aric Sharp CEO of Value Based Care | 2,244,741 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 3, 2024 | Aric Sharp CEO of Value Based Care | 2,107,633 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.23 per share | 2,592,388.59 |
| Jul 3, 2024 | Jamie L. Reynoso CEO, Medicare Advantage | 2,676,975 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 3, 2024 | Jamie L. Reynoso CEO, Medicare Advantage | 2,624,008 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.23 per share | 3,227,529.84 |
| Jun 21, 2024 | Vivek Garipalli Director | 877,567 | Open market or private purchase of non-derivative security Non-derivative transaction at $1.14 per share | 1,000,426.38 |
| Jun 19, 2024 | Karen Soares General Counsel & Secretary | 975,261 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.09 per share | 1,063,034.49 |
| Jun 19, 2024 | Conrad Wai Chief Technology Officer | 2,853,595 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.09 per share | 3,110,418.55 |
| May 21, 2024 | Anna U. Loengard Director | 10,000 | Open market or private purchase of non-derivative security Non-derivative transaction at $0.93 per share | 9,300.00 |
| May 21, 2024 | Anna U. Loengard Director | 15,600 | Open market or private purchase of non-derivative security Non-derivative transaction at $0.96 per share | 14,976.00 |
| May 21, 2024 | Anna U. Loengard Director | 15,110 | Open market or private purchase of non-derivative security Non-derivative transaction at $0.94 per share | 14,203.40 |
Clover Health Investments in the News
California recall candidate banned from viral memestock forum behind GameStop surge
California recall candidate Kevin Paffrath says the meme stock subreddit r/wallstreetbets banned him without warning this week after a profile on his candidacy compared his popular YouTube channel to the viral retail investment forum.
Clover Health short bets mount as stock soars
Short-sellers are battening down the hatches as Clover Health Investments Corp. shares surge.